From May 1, 2023 to July 31, 2023, the company has repurchased 101,000 shares, representing 0.75% for $0.6 million. With this, the company has completed the repurchase of 115,000 shares, representing 0.85% for $0.68 million under the buyback announced on April 5, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.6 USD | -1.08% | +1.55% | -18.15% |
1st Jan change | Capi. | |
---|---|---|
-18.15% | 62.53M | |
+48.07% | 57.87B | |
+41.65% | 40.25B | |
-7.02% | 39.94B | |
-5.96% | 28.54B | |
+12.14% | 26.4B | |
-20.70% | 19.33B | |
+30.11% | 12.4B | |
-0.82% | 12.23B | |
+24.43% | 12.2B |
- Stock Market
- Equities
- CSBR Stock
- News Champions Oncology, Inc.
- Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.